COMMUNIQUÉS West-GlobeNewswire

Philips underlines commitment to Universal Health Coverage at UNGA 74
23/09/2019
September 23, 2019 New report shows how to address the challenges of implementing digital health technology – a catalyst for achieving Universal Health Coverage (UHC) Philips Chief Medical Officer Jan Kimpen discusses [...]
TLC to Present Preclinical Data on TLC178 at ESMO 2019
23/09/2019
TLC178 shows potential as a treatment for sarcomas, with enhanced efficacy, reduced toxicity and decreased dosing frequency SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Sept. 23, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq [...]
Active Biotech: New data on laquinimod from the Phase 2 LEGATO-HD study in Huntington’s disease will be presented at the International congress of Parkinson’s disease and movement disorders
23/09/2019
Lund Sweden, September 23, 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) announces that new data from exploratory analysis of the Phase 2 LEGATO-HD study of laquinimod in Huntington’s disease will be presented at the [...]
Innate Pharma announces clinical data presentations on IPH5401 and monalizumab at ESMO 2019
23/09/2019
INNATE PHARMA ANNOUNCES CLINICAL DATA PRESENTATIONS ON IPH5401 AND MONALIZUMAB AT ESMO 2019 Preliminary results of IPH5401 STELLAR-001, a dose escalation Phase I study in patients with advanced solid tumors 1-year [...]
Innate Pharma annonce la présentation de données cliniques sur IPH5401 et monalizumab au congrès de l’ESMO 2019
23/09/2019
INNATE PHARMA ANNONCE LA PRÉSENTATION DE DONNÉES CLINIQUES SUR IPH5401 ET MONALIZUMAB AU CONGRÈS DE L’ESMO 2019 Données préliminaires issues de STELLAR-001, l’étude de Phase I en escalade de dose évaluant IPH5401 chez [...]
Press Release Biocartis NV: Five Idylla™ Performance Studies to be Presented at ‘European Society for Medical Oncology’ congress
23/09/2019
PRESS RELEASE 23 September 2019, 07:00 CEST Mechelen, Belgium, 23 September 2019 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today [...]
Roche to present new data from its broad oncology portfolio at the European Society for Medical Oncology 2019 Congress
23/09/2019
First positive results from a Phase III cancer immunotherapy combination study in people with previously untreated advanced bladder cancer First results from the BFAST study testing Foundation Medicine’s FoundationOne® [...]
BeiGene Announces Clinical Results on Tislelizumab Presented at the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (CSCO)
23/09/2019
BEIJING, China and CAMBRIDGE, Mass., Sept. 22, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Oncology Venture presents positive data at ESMO on DRP as a response predictor for 5-FU treatment in colorectal cancer
23/09/2019
Press release Hoersholm, Denmark, September 23, 2019 – Oncology Venture A/S (Nasdaq First North Growth Market Stockholm: OV.ST) today announces that data on the ability of DRP ® to predict response to 5-FU anti-cancer [...]
XBiotech annonce l’octroi d’un brevet canadien pour le traitement des pathologies dermatologiques
21/09/2019
AUSTIN, Texas, 21 sept. 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd’hui que l’Office canadien des brevets lui avait octroyé un brevet (brevet n°56003542-6CA) couvrant l’utilisation du [...]
Whole Biome Announces Corporate Name Change to Pendulum Therapeutics
21/09/2019
SAN FRANCISCO, Sept. 20, 2019 (GLOBE NEWSWIRE) -- Whole Biome, an evidence-based microbiome company, announced today that it is changing its corporate name to Pendulum Therapeutics. The name change reflects the company’ [...]
Innate Pharma annonce le dépôt d’un document d’enregistrement Form-F1 en vue de son introduction en bourse envisagée aux Etats-Unis et le dépôt d’un Document d’Enregistrement Universel
20/09/2019
Marseille, France, le 20 septembre 2019, 23:30 INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (« Innate » ou la « Société »), une société de biotechnologie française spécialisée dans la découverte, le [...]
Innate Pharma files registration statement for proposed initial public offering in the United States
20/09/2019
Marseille, France, September 20, 2019 INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (“ Innate ” or the “ Company ”), a French biotechnology company focused on discovering, developing and commercializing [...]
KemPharm Provides Updates Regarding its Board of Directors
20/09/2019
CELEBRATION, Fla., Sept. 20, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that, on [...]
Invitation to the special and extraordinary shareholders' meetings
20/09/2019
Mechelen, Belgium; 20 September 2019, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) invites its shareholders to a special and extraordinary shareholders' meeting. On 14 July 2019, [...]
IGM Biosciences Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
20/09/2019
MOUNTAIN VIEW, Calif., Sept. 20, 2019 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS) today announced the closing of its initial public offering of 12,578,125 shares of its common stock at a price to the public [...]
Invitation to the special and extraordinary shareholders' meetings
20/09/2019
Mechelen, Belgium; 20 September 2019, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) invites its shareholders to a special and extraordinary shareholders' meeting. On 14 July 2019, [...]
Emisphere Development Update
20/09/2019
ROSELAND, N.J., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Novo Nordisk announced today the Federal Food and Drug Administration (FDA) has approved Rybelsus, a semaglutide tablet, for the treatment of adults with type 2 [...]
AVRA Medical Robotics Appoints Two World Renowned Professionals to Chair its Medical and Scientific Advisory Boards
20/09/2019
ORLANDO, Fla., Sept. 20, 2019 (GLOBE NEWSWIRE) -- AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), an emerging company which is building a fully autonomous medical robotic system through the use of new [...]

Pages